Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients.

Erwin F StrasserPhilipp A SteiningerKlaus KornSusanne AchenbachMatthias TenbuschSarah CunninghamRobert ZimmermannKlaus ÜberlaHolger Hackstein

Published in: Transfusion (2020)

The SARS-CoV-2 RNA assay, only licensed for respiratory swabs, performed on a PCR system for high-throughput testing, showed a good assay performance for blood testing.

Keyphrases

high throughput
sars cov
respiratory syndrome coronavirus
single cell
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
coronavirus disease
peritoneal dialysis
prognostic factors
nucleic acid